Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to 0.44.

  • Harvard Bioscience's Debt Ratio rose 5097.76% to 0.44 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44, marking a year-over-year increase of 5097.76%. This contributed to the annual value of 0.29 for FY2024, which is 963.21% up from last year.
  • Per Harvard Bioscience's latest filing, its Debt Ratio stood at 0.44 for Q3 2025, which was up 5097.76% from 0.44 recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Debt Ratio ranged from a high of 0.45 in Q1 2025 and a low of 0.27 during Q4 2023
  • Its 5-year average for Debt Ratio is 0.32, with a median of 0.29 in 2021.
  • As far as peak fluctuations go, Harvard Bioscience's Debt Ratio tumbled by 1736.98% in 2023, and later soared by 6849.7% in 2025.
  • Quarter analysis of 5 years shows Harvard Bioscience's Debt Ratio stood at 0.3 in 2021, then rose by 8.2% to 0.32 in 2022, then decreased by 17.37% to 0.27 in 2023, then rose by 9.63% to 0.29 in 2024, then soared by 49.25% to 0.44 in 2025.
  • Its Debt Ratio stands at 0.44 for Q3 2025, versus 0.44 for Q2 2025 and 0.45 for Q1 2025.